Neuronetics (STIM) EBT Margin Growth (1y) (2018 - 2026)
Neuronetics (STIM) EBT Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -719.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 687.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 88.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 374.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 343.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 84.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -126.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 165.00 |
| 10 | Neuronetics | 221.22 Mn | 201.78 Mn | 21.22 Mn | 1,759.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6,776.00 |
| Mar 31, 2026 | 825.00 |
| Dec 31, 2025 | 4,382.00 |
| Sep 30, 2025 | 1,857.00 |
| Jun 30, 2025 | 1,676.00 |
| Mar 31, 2025 | 893.00 |
| Dec 31, 2024 | -3,160.00 |
| Sep 30, 2024 | 521.00 |
| Jun 30, 2024 | -1,709.00 |
| Mar 31, 2024 | 2,195.00 |
| Dec 31, 2023 | 1,849.00 |
| Sep 30, 2023 | -340.00 |
| Jun 30, 2023 | 2,050.00 |
| Mar 31, 2023 | 3,587.00 |
| Dec 31, 2022 | 303.00 |
| Sep 30, 2022 | 3,989.00 |
| Jun 30, 2022 | 11,041.00 |
| Mar 31, 2022 | 6,690.00 |
| Dec 31, 2021 | -2,797.00 |
| Sep 30, 2021 | -2,877.00 |